Laddar...

Apatinib treatment combined with chemotherapy for advanced epithelial ovarian cancer: a case report

Apatinib is a novel oral tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2, which has been proved by clinical trials to be effective and safe for patients with chemotherapy-refractory gastric cancer. To date, there is no study or case report on apatinib treatment for...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Onco Targets Ther
Huvudupphovsmän: Deng, Linghui, Wang, Yue, Lu, Wenbin, Liu, Qian, Wu, Jie, Jin, Jianhua
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove Medical Press 2017
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5359124/
https://ncbi.nlm.nih.gov/pubmed/28352185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S126471
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!